Clinical Benefits of Eligen® Technology
The oral delivery of certain drugs provides a unique advantage in that oral delivery mimics the physiological path of endogenous secretion of these compounds
Drugs for Hepato-portal Destination
The effects of various anti-viral and chemotherapy drugs could be improved if high concentration in the liver is required, since, when given orally, these drugs are absorbed through the mesenteric veins, travel to the liver via the portal vein.
Improved Compliance and Convenience
Oral delivery is the most convenient, most economical, and the most compliant means of delivering therapeutic agents and is the preferred formulation in the pharmaceutical industry.
Advantageous Pharmacokinetic Profile
One of the key features of the Eligen® Technology is the rapid onset of absorption and drug action which is advantageous for many indications
Commercial Benefits of Eligen® Technology
Since patients prefer to take an oral medication vs. having to personally administer or schedule doctor appointments to receive painful injections, patient compliance is more favorable which results in improved clinical outcomes.
Facilitates the extension of patent life and overall value for priority portfolio assets by developing more advantageous and differentiated formulations
Offers a safer and more cost effective alternative to injectable products in terms of decreasing physician visits and manufacturing costs. That results in a product that is far more patient centric and managed care friendly.
Quicker Regulatory Approval
Provides quick regulatory approval utilizing a technology that has already been “de-risked,” and is typically coupled with APIs that have been previously approved.